30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Mutations in pfdhfr and pfdhps genes have been shown to associate with sulphadoxine-pyrimethamine (SP) resistance of Plasmodium falciparum parasites. However, pfdhfr, pfdhps genotypes and the correlations to SP treatment outcome in Indonesia has not yet been well analysed.

          Methods

          After obtaining informed consent, 61 uncomplicated falciparum malaria patients were recruited in Banjar district, South Kalimantan Province, Indonesia, from October 2009 to August 2010. They were treated by a single oral dose of SP and its effects on clinical and parasitological status were followed until day 28 after treatment. Occasionally, a thick smear blood film for microscopy observation and blood spot on a filter paper for pfdhfr and pfdhps genotype analysis were collected.

          Results

          Pfdhfr and pfdhps genotypes from 24 P. falciparum-infected patients consisting of adequate clinical parasitological response (ACPR) (n = 6; 25.0%) and early treatment failure (ETF) (n = 10; 41.7%) or late parasitological failure (LPF) (n = 8; 33.3%) were obtained by sequencing. Two novel mutations of pfdhps gene, K540T and I588F, were determined in ten and five isolates, respectively. These mutations were present in the pfdhfr/ pfdhps combined haplotypes of AN RNI/S GTGA (n = 6), AN RNL/S GTGA (n = 4), and AN RNI/S GEAA(588 F) (n = 5), (mutation codons are bold typed); these haplotypes were mostly belonging to parasitological failure (ETF or LPF). The parasites acquiring five mutations in pfdhfr/ pfdhps haplotypes and four mutations with additional I588F did not respond adequately to SP treatment.

          Conclusion

          Many of Plasmodium falciparum infected patients in Banjar district, South Kalimantan, Indonesia did not respond adequately to SP treatment and these low ineffectiveness of SP in this area was associated with two novel mutations of pfdhps, K540T and I588F.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

            Molecular assays for monitoring sulfadoxine-pyrimethamine-resistant Plasmodium falciparum have not been implemented because of the genetic and statistical complexity of the parasite mutations that confer resistance and their relation to treatment outcomes. This study analyzed pretreatment dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genotypes and treatment outcomes in a double-blind, placebo-controlled trial of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment for uncomplicated P. falciparum malaria. Multiple logistic regression was used to identify mutations that were predictive of treatment failure and to identify interactions and confounding factors. Infections caused by parasites with 3 DHFR mutations and 2 DHPS mutations (the "quintuple mutant") were associated with sulfadoxine-pyrimethamine treatment failure but not with chlorproguanil-dapsone treatment failure. The presence of a single DHFR mutation (Arg-59) with a single DHPS mutation (Glu-540) accurately predicted the presence of the quintuple mutant. If this model is validated in other populations, it will finally be possible to use molecular markers for surveillance of antifolate-resistant P. falciparum malaria in Africa.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanisms of resistance of malaria parasites to antifolates.

              Antifolate antimalarial drugs interfere with folate metabolism, a pathway essential to malaria parasite survival. This class of drugs includes effective causal prophylactic and therapeutic agents, some of which act synergistically when used in combination. Unfortunately, the antifolates have proven susceptible to resistance in the malaria parasite. Resistance is caused by point mutations in dihydrofolate reductase and dihydropteroate synthase, the two key enzymes in the folate biosynthetic pathway that are targeted by the antifolates. Resistance to these drugs arises relatively rapidly in response to drug pressure and is now common worldwide. Nevertheless, antifolate drugs remain first-line agents in several sub-Saharan African countries where chloroquine resistance is widespread, at least partially because they remain the only affordable, effective alternative. New antifolate combinations that are more effective against resistant parasites are being developed and in one case, recently introduced into use. Combining these antifolates with drugs that act on different targets in the parasite should greatly enhance their effectiveness as well as deter the development of resistance. Molecular epidemiological techniques for monitoring parasite drug resistance may contribute to development of strategies for prolonging the useful therapeutic life of this important class of drugs.
                Bookmark

                Author and article information

                Contributors
                Journal
                Malar J
                Malar. J
                Malaria Journal
                BioMed Central
                1475-2875
                2014
                4 April 2014
                : 13
                : 135
                Affiliations
                [1 ]Medical Science, Graduate School, Faculty of Medicine, Universitas Airlangga, Jl Mayjen Prof Dr Moestopo 47, Surabaya 60131, Indonesia
                [2 ]Department of Medical Parasitology, Faculty of Medicine, Universitas Airlangga, Jl Mayjen Prof Dr Moestopo 47, Surabaya 60131, Indonesia
                [3 ]Malaria Study Group/Laboratory of Malaria, Institute of Tropical Disease, Universitas Airlangga, Kampus C Jl Mulyorejo, Surabaya 60115, Indonesia
                [4 ]Department of Health of Banjar District, Jl Jend A Yani KM 100, Martapura, South Kalimantan Province 70611, Indonesia
                [5 ]Department of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Jl Mayjen Prof Dr Moestopo 47, Surabaya 60131, Indonesia
                [6 ]Tropical Infectious Diseases Hospital, Kampus C Universitas Airlangga, Kampus C Jl Mulyorejo, Surabaya 60115, Indonesia
                [7 ]Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
                Article
                1475-2875-13-135
                10.1186/1475-2875-13-135
                4222776
                25187019
                e0570bef-b776-4716-8840-586338ccda5e
                Copyright © 2014 Basuki et al.; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 23 December 2013
                : 25 March 2014
                Categories
                Research

                Infectious disease & Microbiology
                plasmodium falciparum,sulphadoxine-pyrimethamine,pfdhfr,pfdhps

                Comments

                Comment on this article